Posttranslational knockdown of a specific protein is an attractive approach for examining its function within a system. Here we introduce phospho-dependent proteolysis targeting chimeras (phosphoPROTACs), a method to couple the conditional ...PNAS, 1 week ago Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma Elites TV, 1 week ago Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder Elites TV, 2 weeks ago Association of the Protein-Tyrosine Phosphatase DEP-1 with Its Substrate FLT3 Visualized by In Situ Proximity Ligation Assay Elites TV, 3 weeks ago
A Disintegrin and Metalloproteinases (ADAMs) are the principal enzymes for shedding receptor tyrosine kinase (RTK) ectodomains and ligands from the cell surface. Multiple layers of activity regulation, feedback, and catalytic promiscuity impede our ...PNAS, 1 week ago
Activated G protein-coupled receptors (GPCRs) and receptor tyrosine kinases relay extracellular signals through spatial and temporal controlled kinase and GTPase entities. These enzymes are coordinated by multifunctional scaffolding proteins for ...PNAS, 2 weeks ago
medwireNews: Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor (TKI) therapy in patients with epidermal growth factor receptor (EGFR)-activating, non-small-cell lung cancer ...MedWire News, 2 weeks ago PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022 Sys-Con Media, 3 days ago United States chronic myeloid leukemia market: Latest market research analysed TransWorldNews, 3 days ago Global Bosulif market: New market research published TransWorldNews, 3 days ago
Data Presented at ARVO 2013 Annual Meeting Demonstrated Potential of Kala's Proprietary Mucosal-Penetrating Particle Technology for Ocular Disease ARVO 2013 WALTHAM, Mass.--( Topical RTKi-MPP showed a 5-fold enhancement in retinal drug ...Drugs.com, 2 weeks ago Kala Provides Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor Individual.com, 2 weeks ago Kala Pharmaceuticals Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor BioSpace, 2 weeks ago Langer's Kala touts positive results for topical wet AMD treatment FiercePharma, 2 weeks ago
EU Regulatory Authorities Grant Orphan Status to Eisai's Lenvatinib for the Treatment of Radioiodine-Refractory..
HATFIELD, England Orphan status also granted in Switzerland The investigational multi-tyrosine kinase inhibitor (TKI), lenvatinib (development code: E7080), has today been granted orphan drug designation (ODD) for the treatment of follicular and ...ADVFN UK, 2 weeks ago
More from: OSIX News, Reuters UK...and 11 other sources
Studies from Shanghai Jiaotong University in the Area of Receptor Protein-Tyrosine Kinases Described
(NewsRx) -- By a News Reporter-Staff News Editor at Angiogenesis Weekly -- Data detailed on Enzymes and Coenzymes have been presented. According to news reporting from Shanghai, People's Republic of China, by NewsRx journalists, research stated, "To ...NewsRX, 1 day ago New Findings Reported from National Institutes of Health Describe Advances in Receptor Protein-Tyrosine Kinases NewsRX, 1 week ago Study Results from University of Georgia Provide New Insights into Protein Tyrosine Phosphatases NewsRX, 2 weeks ago Data from Eli Lilly Advance Knowledge in Proteomics NewsRX, 1 day ago
More from: , NewsRX...and 1 other sources
Profiling Epidermal Growth Factor Receptor and Heregulin Receptor 3 Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technology
by Mohammed Akli Ayoub, Heng B. See, Ruth M. Seeber, Stephen P. Armstrong, Kevin D. G. Pfleger Heteromerization can play an important role in regulating the activation and/or signal transduction of most forms of receptors, including receptor ...Elites TV, 5 days ago ArQule to Report First Quarter 2013 Financial Results on May 8, 2013 PharmiWeb, 2 days ago Investigators at University of Pennsylvania Discuss Findings in Breast Cancer NewsRX, 2 days ago Ariad Pharmaceuticals Inc. Presents at UBS Global Healthcare Conference, May-20-2013 08:30 AM Seeking Alpha, 6 days ago
Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular docking
This content is free, please choose one of the three options provided in the Log in section to gain access. Please choose one of the options provided in the log in section to gain access to this content: Vascular endothelial growth factor receptor-2 ...RSC, 2 weeks ago Analysis of Serum Metabolites for the Discovery of Amino Acid Biomarkers and the Effect of Galangin on Cerebral Ischemia RSC, 2 days ago
on your WebpageAdd Widget >Get your members hooked!